Quality Control News and Research

RSS

All-atom models reveal novel protein misfolding mechanism

New computer simulations that model every atom of a protein as it folds into its final three-dimensional form support the existence of a recently identified type of protein misfolding.

8 Aug 2025

LabConnect deploys Sapio LIMS across global operations

Sapio Sciences, the science-aware™ lab informatics platform, today announced the full deployment of Sapio LIMS at LabConnect.

From Sapio Sciences 7 Aug 2025

Scientists map the genes behind diet and dementia risk

Researchers established a high-quality genetic dataset from the MIND diet trial, enabling new studies of gene–diet interactions in cognitive health. This resource allows deeper investigation into why individuals respond differently to dietary interventions targeting dementia risk.

6 Aug 2025

Breakthrough study reveals potential treatment path for ALS

Amyotrophic lateral sclerosis (ALS), known as Lou Gehrig's disease, is an incurable neurological disorder affecting motor neurons-nerve cells in the brain and spinal cord that control voluntary muscle movement and breathing.

5 Aug 2025

HIV trial points to semaglutide as a new anti-aging contender

Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by multiple DNA methylation clocks in a randomized controlled trial. These exploratory findings suggest GLP-1 receptor agonists could impact biological aging but require further validation in broader populations.

4 Aug 2025

Study sheds light on molecular mechanisms of brain aging

Aging and neurodegeneration are both known to disrupt the production of functional proteins in cells – a process called "proteostasis," or protein homeostasis.

31 Jul 2025

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Discover how twin screw granulation enables continuous, solvent free drug amorphization—expert insights from Thermo Fisher Scientific’s Maggie Richter.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 30 Jul 2025

Scientists open new atlas of genetic diversity with advanced sequencing

A global team mapped over 100,000 structural variants in human genomes by applying Oxford Nanopore long-read sequencing and a novel graph-based analytical approach to samples from 26 populations. The study reveals the extraordinary complexity and diversity of human DNA, providing an open-access atlas that will accelerate discoveries in genetic disease and human evolution.

24 Jul 2025

Insights into antibiotic resistance and virulence of Bordetella hinzii

Announcing a new article publication for Zoonoses journal. This study was aimed at analyzing the pathogenic characteristics of Bordetella hinzii (B. hinzii), and elucidating its antibiotic resistance mechanisms, virulence gene distribution, and vaccine development potential.

23 Jul 2025

Optimal Group joins SciY

The SciY business today announced the integration of Optimal Industrial Technologies and Optimal Industrial Automation into the SciY Laboratory Digitalization Suite, creating a single, vendor-agnostic software and automation platform that connects molecular research and development, quality control labs, and full-scale biopharma and specialty chemicals manufacturing environments.

From SciY 22 Jul 2025

DeNovix releases new CellDrop FLxi applications

DeNovix announces the release of three new cell counting applications for the CellDrop FLxi Automated Cell Counter.

From DeNovix Inc. 21 Jul 2025

Developing AI-driven stem cell therapies to fight ovarian aging

Ovarian aging, characterized by diminishing egg reserves and quality, affects millions of women worldwide, often leading to infertility.

18 Jul 2025

NIST releases first publicly consented pancreatic cancer genome data

In an effort to foster progress in cancer research, the National Institute of Standards and Technology (NIST) is releasing detailed and comprehensive data about the entire genetic content of a pancreatic cancer cell.

16 Jul 2025

Yourgene Health launches LightBench Discover

Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces the launch of LightBench® Discover, a high-precision 3-in-1 instrument for genomic research labs conducting long-read sequencing.

15 Jul 2025

Study reveals key role of Egr-1 in controlling autoimmune diseases

Autoimmune diseases, like multiple sclerosis result when the body's immune system starts to attack its own cells. Regulatory T cells, a subtype of T cells play a critical role in suppressing these attacks.

14 Jul 2025

Exploring the roles of orphan nuclear receptors in MASLD pathogenesis

Metabolic dysfunction-associated steatotic liver disease (MASLD), affecting approximately 30% of the global population, represents a spectrum of liver disorders ranging from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, and cirrhosis.

12 Jul 2025

Egr-1 gene identified as crucial regulator of regulatory T cells in multiple sclerosis

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect millions of people worldwide.

11 Jul 2025

How a simple blood test can forecast future health risks

Plasma proteomics reveals that the biological ages of key organs, especially the brain and immune system, strongly predict the risk of future disease and early death. These organ-specific “clocks” provide a new tool for identifying those at highest risk and personalizing preventive care.

10 Jul 2025

Research reveals Ghanaian children face high cancer risk from local fish

Researchers found that most fish sampled from Ghana’s Keta Lagoon had arsenic and mercury levels exceeding World Health Organization limits. Health risk assessments show these contaminants pose significant cancer and non-cancer risks, especially for children.

8 Jul 2025